NG
BMY icon

NWK Group’s Bristol-Myers Squibb BMY Stock Holding History

NWK Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,132
Closed -$135K – 109
2021
Q1 		$135K Hold
2,132
– – 0.06% 70
2020
Q4 		$132K Hold
2,132
– – 0.06% 68
2020
Q3 		$129K Buy
2,132
+900
+73% +$54.2K 0.06% 66
2020
Q2 		$72K Hold
1,232
– – 0.04% 73
2020
Q1 		$69K Hold
1,232
– – 0.06% 72
2019
Q4 		$79K Buy
+1,232
New +$70.6K 0.07% 83

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

NWK Group's BMY Position: Q2 2021 in Review

NWK Group sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 2,132 shares — an estimated $135K sold.

NWK Group first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $135K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • NWK Group reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • NWK Group sold 2,132 Bristol-Myers Squibb shares in Q2 2021, an estimated $135K.
  • NWK Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
  • NWK Group's Bristol-Myers Squibb position peaked at $135K in Q1 2021.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.